KLRS vs AAPL: Which Stock is Better?
Side-by-side comparison of Kalaris Therapeutics Inc and Apple Inc in 2026
KLRS
Kalaris Therapeutics Inc
$5.87
AAPL
Apple Inc
$263.58
Key Metrics Comparison
| Metric | KLRS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $144.68M | N/A | KLRS |
| P/E Ratio | N/A | 32.80 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | 0.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze KLRS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KLRS or AAPL a better investment?
Comparing KLRS and AAPL: Kalaris Therapeutics Inc has a market cap of $144.68M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KLRS and AAPL?
KLRS (Kalaris Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KLRS or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KLRS or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.0% for KLRS.
Which company is more profitable: KLRS or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for KLRS.
Which is the larger company: KLRS or AAPL?
Kalaris Therapeutics Inc (KLRS) is larger with a market cap of $144.68M compared to N/A for AAPL.
Should I buy KLRS or AAPL in 2026?
Both KLRS and AAPL have investment merit. KLRS trades at $5.87 while AAPL trades at $263.58. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KLRS and AAPL stock?
Key differences: Market Cap ($144.68M vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).